Like Snail inhibitors, histone modification agents are emerging as feasible therapeutic strategies capable of relaxing the DNA, making it more accessible for transcription and ultimately leading to changes in gene expression while sensitizing tumor cells to chemotherapy [25]. This evidence concerns the gene SNAI1 and neoplasm.